Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
The effect and safety of sleep interventions on suicidal thoughts and behavior - A systematic review and
Paula von Spreckelsen1, Daan Schouten2,3, Natasha G Waslam1
1113 Suicide Prevention, Amsterdam, the Netherlands.
Background:
Sleep disturbances are a risk factor for suicidal ideation, suicide attempts and suicide. While recent findings suggest that improving sleep by psychotherapeutic sleep interventions exerts a positive effect on suicidality, there are also indications that certain sleep medications are associated with an increased risk for suicidality. Given these discrepancies, the current study systematically reviewed the effect of non-pharmacological and pharmacological sleep interventions on suicidality.
Methods:
A systematic literature search of various scientific databases was conducted (March 2025). Randomized controlled trials that examined the effect of sleep interventions on suicidality were searched for.
Results:
The search strategy resulted in 5037 unique articles. A total of k = 44 articles (N = 14965 participants) were included in the systematic review. The results indicate that sleep interventions, particularly psychotherapeutic sleep treatments (g = -0.17, [-0.26 to -0.08]), result in a small significant reduction of suicidal ideation. No conclusive evidence was found for the effect or safety of pharmacotherapy or light therapy targeting sleep disturbance on suicidality. The findings should be interpreted in light of the limited number of studies with often small sample sizes, methodological inconsistencies in monitoring suicidality as an adverse event, restrictions on the inclusion of people with suicidality, and reliance on suicidal ideation as an outcome measure of suicidality.
Conclusion:
Health care professionals are recommended to apply psychotherapeutic sleep interventions, such as cognitive behavioral therapy for insomnia, to reduce suicidal ideation in clients with disturbed sleep. When prescribing medications for disturbed sleep, we recommend professionals to closely monitor clients for potential adverse effects on suicidality.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Management of Insomnia
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...